Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Low Urin Tract Symptoms ; 11(3): 109-114, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30251330

RESUMEN

OBJECTIVE: The aim of this study was to investigate the efficacy and safety of tadalafil add-on therapy with α1 -adrenoceptor antagonists. METHODS: Patients with persistent storage symptoms refractory to α1 -adrenoceptor antagonists for benign prostatic hyperplasia were enrolled in the study. Patients were randomly assigned to either a 5 mg tadalafil or 5 mg solifenacin treatment group for 12 weeks. International Prostate Symptom Score, Overactive Bladder Symptom Score, urinary flow rates, residual urine volume, and blood pressure were measured prospectively before treatment and after 4 and 12 weeks of treatment. Changes from baseline were compared between groups. The rate of treatment discontinuation due to adverse effects was evaluated. RESULTS: Of the 75 patients recruited to the study, 38 and 37 were assigned to the tadalafil and solifenacin groups, respectively. There were no significant difference in baseline characteristics between the two groups. The change in the amount of residual urine volume was significantly larger in the solifenacin- than tadalafil-treated group; other parameters, including lower urinary tract symptoms and uroflowmetry measures, did not differ significantly between the two groups. Seven (18%) and 12 (32%) patients in the tadalafil and solifenacin groups, respectively, discontinued treatment because of adverse events. The main reasons for discontinuation in the tadalafil group were stomach discomfort or nausea and dizziness or vertigo; voiding difficulty and constipation were the main reasons for discontinuation in the solifenacin group. There was no significant difference in blood pressure fluctuations from baseline between the two groups. CONCLUSIONS: Tadalafil add-on therapy was not inferior to solifenacin add-on therapy in terms of effect and safety. Therefore, tadalafil could be an alternative add-on drug for patients with persistent lower urinary tract symptoms refractory to α1 -adrenoceptor antagonists.


Asunto(s)
Hiperplasia Prostática/complicaciones , Prostatismo/tratamiento farmacológico , Succinato de Solifenacina/uso terapéutico , Tadalafilo/uso terapéutico , Agentes Urológicos/uso terapéutico , Antagonistas de Receptores Adrenérgicos alfa 1/uso terapéutico , Anciano , Anciano de 80 o más Años , Quimioterapia Combinada , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Prostatismo/etiología , Índice de Severidad de la Enfermedad , Succinato de Solifenacina/efectos adversos , Tadalafilo/efectos adversos , Agentes Urológicos/efectos adversos
2.
Exp Clin Transplant ; 12(6): 559-61, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25020145

RESUMEN

In kidney transplant recipients, acute renal failure resulting from a ureteral obstruction by fungus balls is uncommon. We report a 60-year-old man diagnosed with ureteral obstruction caused by Candida albicans fungus balls early after transplant. Diagnosis was made by a T2-weighted magnetic resonance image, which demonstrated fungus balls as a low-intensity mass in the pelvis and microscopic examination findings in the urine. The patient was treated successfully with an antifungal agent and direct irrigation. It should be noted that fungus balls may cause ureteral obstruction of transplanted kidneys, possibly resulting in graft failure. Imaging of the kidneys and collecting system and aggressive debridement that adds to systemic therapy are necessary for early diagnosis and are central to a successful outcome.


Asunto(s)
Bezoares , Candida albicans/patogenicidad , Candidiasis/microbiología , Trasplante de Riñón/efectos adversos , Imagen por Resonancia Magnética , Obstrucción Ureteral/diagnóstico , Obstrucción Ureteral/microbiología , Administración Oral , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Candidiasis/diagnóstico , Candidiasis/terapia , Fluconazol/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Irrigación Terapéutica/métodos , Resultado del Tratamiento , Obstrucción Ureteral/terapia
3.
Springerplus ; 2: 348, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23961412

RESUMEN

OBJECTIVES: To validate the feasibility and implications of a hybrid procedure using perineal and abdominal approaches for a radical prostatocystectomy. METHODS: Between March 2007 and May 2012, we performed 16 prostatocystectomy and simultaneous urethrectomy under a hybrid procedure using perineal and abdominal approach for advanced bladder cancer. The hybrid procedure was selected in each case, because of prostatic urethra involvement in 13 and prior treatment in 3 (irradiation, radical retropubic prostatectomy, and sigmoidectomy, respectively). Two surgical teams, one responsible for the perineal approach and the other for the abdominal portion, performed the operation. RESULTS: The median operation time for the prostatocystectomy procedure was 207 minutes and median intraoperative blood loss was 1665 ml. The en bloc removal of the specimen was perfectly performed and no intraoperative difficulties and intraoperative complications such as rectal injury were recognized in all cases. As for postoperative complications associated with the exaggerated lithotomy position, neurologic complications and rhabdomyolysis which could be treated conservately were found in 1 case. Although 5 patients died from distant metastasis, local recurrence was not seen in any of the 16 patients during the follow-up period. CONCLUSION: The hybrid procedure using perineal and abdominal approach for radical prostatocystectomy is a well-organized procedure that can provide good visualization of the surgical structure around the prostate, leading to a reduction in or prevention of local recurrence and surgical complications even in the selected patient.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...